Skip to content

The effect of vitamin D3 supplement on pregnancy outcomes

Compare the effect of vitamin D and calcium plus vitamin D on pregnancy outcomes in pregnant women

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016121430612N2
Enrollment
460
Registered
2016-12-26
Start date
2015-03-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vitamin D deficiency. Vitamin D deficiency

Interventions

Intervention 1: Control group: Ca-D supplement contains 400 UI vitamin D daily from 16 weeks until the end of the pregnancy was received. Intervention 2: Intervention group: Vitamin D3 daily, oral 100
Prevention
Control group: Ca-D supplement contains 400 UI vitamin D daily from 16 weeks until the end of the pregnancy was received.
Intervention group: Vitamin D3 daily, oral 1000UI from 16 weeks until the end of the pregnancy is used. Also, this group according to routine prenatal care, ca-D supplement contains 400 UI vitamin D d

Sponsors

Hormozgan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Gestational age less than 10 weeks of gestation; with no history of diabetes; hypertension; a history of polycystic ovary syndrome; lack of family history of diabetes in first-degree relatives; no family history of high blood pressure in first-degree relatives; tend the sick; the vitamin D <30ng / L in patients 10-6 weeks of pregnancy; body mass index between 19-26; lack of vitamin D during the last 6 months; singleton pregnancy; gestational first to third; Iran. Exclusion criteria: Unwillingness to participate in the study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Vitamin D concentration in serum of pregnant women. Timepoint: Third trimester of pregnancy. Method of measurement: Blood exam.

Secondary

MeasureTime frame
Diabete. Timepoint: since 16weeks until the end of pregnancy. Method of measurement: The record information of pregnant women.;Preeclamsia. Timepoint: since 16weeks until the end of pregnancy. Method of measurement: The record information of pregnant women.;Preterm delivery. Timepoint: since 16weeks until the end of pregnancy. Method of measurement: The record information of pregnant women.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Najmehsadat Mosalanejad

Hormozgan University of Medical Sciences

nmosalanezhad467@gmail.commosalanejad@hums.ac.ir+98 76 3333 7192

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026